Health Care & Life Sciences » Pharmaceuticals | Cosmo Pharmaceuticals

Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 15.04 M
Public Float
 -
Cosmo Pharmaceuticals N.V.
Stock Exchange SIX Swiss Exchange
EPS
 CHF1.38
Market Cap
 CHF1.46 B
Shares Outstanding
 15.04 M
Public Float
 7.57 M

Profile

Address
Riverside II
Dublin Dublin 2
Ireland
Employees -
Website http://www.cosmopharma.com
Updated 07/08/2019
Cosmo Pharmaceuticals NV engages in the development, manufacturing and distribution of treatments for gastrointestinal diseases, endoscopy, colorectal cancer diagnosis, and colonoscopy. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland. .

Financials

View All

Hans Christoph Tanner
Executive Director & Head-Transactions Office
Eimar Cowhey
Non-Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.